Ventilator News and Research RSS Feed - Ventilator News and Research

HAMILTON-C1 provides optimal ventilation therapy for neonates

HAMILTON-C1 provides optimal ventilation therapy for neonates

The high‐performance capabilities of the HAMILTON‐C1 with the new Neonatal option include lung protective strategies and adaptive ventilation modes to ensure that each baby receives treatment tailored to its specific needs. Requiring only a minimum of space, the HAMILTON‐C1 combines high reliability, ease of use and maximum mobility with optimal performance for your most fragile patients. [More]
FDA grants QIDP and Fast Track designation to Nabriva's lefamulin for treatment of CABP, ABSSSI

FDA grants QIDP and Fast Track designation to Nabriva's lefamulin for treatment of CABP, ABSSSI

Nabriva Therapeutics AG, a biotechnology company focused on developing pleuromutilins, a new class of antibiotics for the treatment of serious infections caused by resistant Gram-positive and Gram-negative pathogens, announced today that the United States Food and Drug Administration has granted Qualified Infectious Disease Product (QIDP) as well as Fast Track status designation to Nabriva's lead product lefamulin, for the treatment of community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI). [More]
Study: Benzodiazepine sedatives may increase death risk in patients receiving mechanical ventilation

Study: Benzodiazepine sedatives may increase death risk in patients receiving mechanical ventilation

Sedation is frequently required for mechanically ventilated intensive care unit (ICU) patients to reduce anxiety, provide comfort, and assist in providing optimal respiratory support. [More]
Synapse Biomedical completes enrollment in post-approval study of NeuRx DPS for ALS patients

Synapse Biomedical completes enrollment in post-approval study of NeuRx DPS for ALS patients

Synapse Biomedical Inc. announced today it has completed the enrollment of the post-approval study of its NeuRx DPS System for ALS patients. [More]
Seattle Children's Research Institute receives grant to improve health of infants with heart defects

Seattle Children's Research Institute receives grant to improve health of infants with heart defects

The U.S. Food and Drug Administration's Office of Orphan Products Development has awarded Seattle Children's Research Institute a $1.6 million grant to lead a 4-year, multi-site clinical trial aimed at improving long-term health in infants born with a heart defect. [More]
DNA sequencing may lead to greater care for patients with ventilator-associated pneumonia

DNA sequencing may lead to greater care for patients with ventilator-associated pneumonia

A patient survives life-threatening trauma, is intubated in the intensive care unit (ICU) to support his or her affected vital functions, starts to recover, and then develops pneumonia. [More]
Highlights: Hawaii public hospital cuts; La. struggles with state worker health program costs; aging in Ky.

Highlights: Hawaii public hospital cuts; La. struggles with state worker health program costs; aging in Ky.

Public hospitals across Hawaii are finding ways to reduce staff and cut services because they don't have enough money to make ends meet. Executives from the Hawaii Health Systems Corp. told lawmakers Friday that even after layoffs they are facing a $30 million deficit in 2015. One hospital on Maui chose to close its adolescent psychology unit because it couldn't sustain the appropriate staffing levels to provide the services. It's also considering cuts to oncology and dialysis services if the situation doesn't improve (9/20). [More]
Hospitals see sharp declines in rates of CLABSIs and ventilator-associated pneumonias

Hospitals see sharp declines in rates of CLABSIs and ventilator-associated pneumonias

Hospitals across the country have seen sharp declines in rates of central line-associated blood stream infections (CLABSIs) and ventilator-associated pneumonias (VAPs) among critically ill neonates and children, according to a new study in the journal Pediatrics. [More]
State highlights: Mass. health spending slows, but for how long?

State highlights: Mass. health spending slows, but for how long?

Two years ago, Massachusetts set what was considered an ambitious goal: The state would not let that persistent monster, rising health care costs, increase faster than the economy as a whole. [More]
Cancer fighter may also help patients survive pneumonia

Cancer fighter may also help patients survive pneumonia

The tip of an immune molecule known for its skill at fighting cancer may also help patients survive pneumonia, scientists report. [More]
Expert guidance helps prioritize strategies to prevent VAP

Expert guidance helps prioritize strategies to prevent VAP

Thousands of critically ill patients on life support develop ventilator-associated pneumonia (VAP) each year. A new document released today by a consortium of professional organizations helps prioritize strategies to prevent this potentially fatal infection. [More]
Novel oxygen uptake parameter aids idiopathic PAH evaluation

Novel oxygen uptake parameter aids idiopathic PAH evaluation

Oxygen uptake efficiency plateau, measured during the cardiopulmonary exercise test, offers a novel method for evaluating gas exchange abnormalities in patients with idiopathic pulmonary hypertension, Chinese researchers report. [More]
AACN conference addresses educational, professional development goals for progressive care nurses

AACN conference addresses educational, professional development goals for progressive care nurses

AACN Progressive Care Pathways, presented by the American Association of Critical-Care Nurses, is the only conference to address the distinct educational and professional development goals for the growing number of nurses who care for high acuity patients who are not in the ICU but require highly skilled nursing care. [More]
Cubist Pharmaceuticals' SIVEXTRO receives FDA approval for treatment of ABSSSI

Cubist Pharmaceuticals' SIVEXTRO receives FDA approval for treatment of ABSSSI

Cubist Pharmaceuticals, Inc. announced today the U.S. Food and Drug Administration approved SIVEXTRO (tedizolid phosphate) for the treatment of adult acute bacterial skin and skin structure infections (ABSSSI). [More]
Longer looks: Caregivers effort to stay well; patients who turn to religion for cures; new views on postpartum depression

Longer looks: Caregivers effort to stay well; patients who turn to religion for cures; new views on postpartum depression

More than 65 million people, or 29 percent of the U.S. population, provide care for a chronically ill, disabled or aged family members or friends during any given year, and spend an average of 20 hours per week providing that care. [More]
UCF College of Nursing interim dean receives NIH grant to improve care for critically-ill patients

UCF College of Nursing interim dean receives NIH grant to improve care for critically-ill patients

More than one hospital television drama has played out an emergency room scene where a patient has to be "tubed" to re-establish breathing. [More]
Cubist Pharmaceuticals publishes positive results from Phase 3 clinical trial of SIVEXTRO

Cubist Pharmaceuticals publishes positive results from Phase 3 clinical trial of SIVEXTRO

Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that The Lancet Infectious Diseases published online the positive results from ESTABLISH-2, a pivotal Phase 3 clinical trial of the investigational antibiotic SIVEXTRO™ (tedizolid phosphate), which is being developed for the treatment of acute bacterial skin and skin structure infections (ABSSSI) and complicated skin and soft tissue infections (cSSTI). [More]
First Edition: June 3, 2014

First Edition: June 3, 2014

Today's headlines include coverage of Medicare data released Monday indicating that 2012 charges for some common inpatient hospital procedures dramatically increased over the previous year. [More]
Patients with chronic pulmonary thromboembolic disease may benefit from PTE

Patients with chronic pulmonary thromboembolic disease may benefit from PTE

Patients with chronic pulmonary thromboembolic disease may benefit from pulmonary thromboendarterectomy (PTE), even if the patients don't have severe pulmonary hypertension, according to University of California, San Diego, researchers. [More]

iMDsoft provides tele-health solutions that ensure best possible remote care

iMDsoft is committed to providing tele-health solutions that ensure the best possible remote care. The company's tele-ICU solution, MVcentralTM, enables intensivists to provide care around the clock from a remote command center and communicate with the hospital-based clinical team. [More]